NKMAX Co. Ltd.

NKMAX Co. Ltd. Share · KR7182400002 (XKOS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NKMAX Co. Ltd.
No Price
Share Float & Liquidity
Free Float 40,87 %
Shares Float 34,95 M
Shares Outstanding 85,52 M
Invested Funds

The following funds have invested in NKMAX Co. Ltd.:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
72,53
Percentage (%)
0,07 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
63,08
Percentage (%)
0,02 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
319,33
Percentage (%)
0,02 %
Company Profile for NKMAX Co. Ltd. Share
NKMAX CO., Ltd. manufactures and sells biological products in South Korea. The company offers anti-cancer immunotherapy treatment that activates the immune cells in body to kill the cancer cells; natural killer cell activity test for cancer patients; NK VUE Kit, an NK cell activity test that quantitatively measures IFN-gamma released from activated NK cells with small amount of blood; and NK365, a proprietary blend of vitamins, minerals, and agaricus mushroom extract for immune system. It also provides recombinant proteins and monoclonal antibodies; and NK PUPPY, a test that measures dog's immunity. The company was formerly known as ATGen Co and changed name to NKMAX CO., Ltd. in 2019. NKMAX CO., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

Company Data

Name NKMAX Co. Ltd.
Company NKMAX Co. Ltd.
Website https://www.nkmax.com
Primary Exchange XKOS KOSDAQ
ISIN KR7182400002
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Sangwoo Park
Market Capitalization 173 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address 172, Dolma-ro, 13605 Seongnam-si
IPO Date 2015-10-23

Stock Splits

Date Split
08.12.2025 1:5
21.12.2023 2:1
27.12.2017 2:1

Ticker Symbols

Name Symbol
KOSDAQ 182400.KQ
More Shares
Investors who hold NKMAX Co. Ltd. also have the following shares in their portfolio:
BNY Mellon Small Cap Stock Index Fund Investor Shares
BNY Mellon Small Cap Stock Index Fund Investor Shares Fund
GUARANTY BANCSHARES INC
GUARANTY BANCSHARES INC Share